SCHEDULE: Health Catalyst: Major Stakeholder Group Reports Ownership Update

A significant stakeholder group, including Stoney Lonesome HF LP and Coghill Capital Management LLC, has updated its beneficial ownership filing for Health Catalyst, Inc., reporting a combined 9.6% stake.

Summary

• This filing is an amendment to a Schedule 13G, reporting changes in beneficial ownership of Health Catalyst, Inc. common stock.
• The reporting persons include Stoney Lonesome HF LP, Coghill Capital Management LLC, Drake Helix Holdings, LLC, CDC Financial, Inc., and Clint D. Coghill.
• As of June 30, 2026, the aggregate beneficial ownership reported by the group is 7,095,498 shares, representing approximately 9.6% of the outstanding common stock.
• This percentage is based on 73,894,020 shares outstanding as of May 22, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports on beneficial ownership changes and does not contain new financial performance data or strategic shifts.

Positives

• The filing clarifies the beneficial ownership structure for a significant portion of Health Catalyst's stock.
• The reporting persons have disclaimed beneficial ownership of securities they do not directly own, providing transparency.

Negatives

• The filing does not provide any new financial performance data or operational updates for Health Catalyst, Inc.

Risks

• Potential for future changes in beneficial ownership by this group could impact stock price or corporate strategy.
• Concentration of ownership among a few reporting persons could influence control or strategic decisions.

Future Outlook

No forward-looking statements or guidance are provided in this filing, as it pertains to ownership disclosure.

Management Comments

• Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.
• The filing of this Schedule 13G shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that such Reporting Person does not directly own.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant shareholders to report their holdings. This update indicates a substantial, consolidated interest in Health Catalyst, Inc. by the reporting group.

Comparison to Industry Standards

• The reported 9.6% ownership by the group is a significant stake, often considered substantial for an institutional investor or a group acting in concert, potentially influencing corporate actions.
• Industry standards for Schedule 13G filings require timely disclosure of beneficial ownership exceeding 5% of a class of securities.

Stakeholder Impact

• Shareholders: The consolidated ownership by this group may influence future strategic decisions or potential corporate actions, impacting shareholder value.
• Management: The significant stake held by the reporting persons could lead to increased engagement or influence on the company's board and management.

Next Steps

• The reporting persons will continue to monitor their beneficial ownership of Health Catalyst, Inc. shares.
• Future amendments to Schedule 13G will be filed if ownership levels change significantly or if the nature of their holdings changes.

Key Dates

Keywords

beneficial ownership, Schedule 13G, Health Catalyst, stakeholder, investment management, corporate governance, stock ownership